Showing results (171-180 of 667) with videos related to
Sort By:
Pageof 67
JCO Precision Oncology|January 16, 2020
Decision-Making Preferences About Secondary Germline Findings That Arise From Tumor Genomic Profiling Among Patients With Advanced CancersJada G Hamilton, Elyse Shuk, Margaux Genoff Garzon, et al.Cancer|March 26, 2003
Epithelial lesions in prophylactic mastectomy specimens from women with BRCA mutationsNoah D Kauff, Edi Brogi, Lauren Scheuer, et al.Oncogene|October 10, 2002
Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancersWilliam B Archey, Kristen A McEachern, Mark Robson, et al.Familial Cancer|June 14, 2005
The TP53 mutational spectrum and frequency of CHEK2*1100delC in Li-Fraumeni-like kindredsRina Siddiqui, Kenan Onel, Flavia Facio, et al.Cancer|February 8, 2017
Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinomaRyan P Kopp, Kelly L Stratton, Emily Glogowski, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2003
TGFBR1*6A and cancer risk: a meta-analysis of seven case-control studiesVirginia G Kaklamani, Nanjiang Hou, Yiansong Bian, et al.The American Journal of Surgical Pathology|December 23, 2004
Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasmsJinru Shia, David S Klimstra, Khedoudja Nafa, et al.BMJ Open|October 10, 2019
Health outcomes, utility and costs of returning incidental results from genomic sequencing in a Canadian cancer population: protocol for a mixed-methods randomised controlled trialSalma Shickh, Marc Clausen, Chloe Mighton, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 12, 2019
Effectiveness of the Genomics ADvISER decision aid for the selection of secondary findings from genomic sequencing: a randomized clinical trialYvonne Bombard, Marc Clausen, Salma Shickh, et al.Familial Cancer|March 12, 2013
Prevalence of HOXB13 mutation in a population of Ashkenazi Jewish men treated for prostate cancerShaheen Alanee, Sohela Shah, Joseph Vijai, et al.Pageof 67